The Aldose Reductase Controversy
- 1 February 1994
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 43 (2) , 169-172
- https://doi.org/10.2337/diab.43.2.169
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Tolrestat for Mild Diabetic Neuropathy: A 52-Week, Randomized, Placebo-Controlled TrialAnnals of Internal Medicine, 1993
- Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with SorbinilNew England Journal of Medicine, 1988
- Prevention of Pericyte Ghost Formation in Retinal Capillaries of Galactose-Fed Dogs by Aldose Reductase InhibitorsArchives of Ophthalmology (1950), 1988
- The effect of sorbinil treatment on red cell sorbitol levels and clinical and electrophysiological parameters of diabetic neuropathyZeitschrift für Neurologie, 1986
- Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trialDiabetologia, 1985
- Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathyDiabetologia, 1984
- RCapillaries: Basement Membrane Thickening by Galactosemia Prevented with Aldose Reductase InhibitorScience, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983
- IMPLICATIONS OF ALDOSE REDUCTASE IN CATARACTS IN HUMAN DIABETES1979
- Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in DiabetesScience, 1966